Lucrin and malignant neoplasm progression Patient Reports February 11, 2012

Lucrin Side Effects Report #5337494-3
Lucrin side effect was reported by a Consumer or non-health professional from BELGIUM on May 21, 2007. Male patient, 81 years of age, was diagnosed with prostate cancer  and was treated with Lucrin. After drug was administered, patient experienced the following side effects: azotaemia, hydronephrosis, malignant neoplasm progression, metastases to bone, metastases to liver, metastases to lymph nodes, prostate cancer . Lucrin dosage: 3.75 MG (3.75 MG, 1 IN 1 M);. During the same period patient was treated with CYPROTERONE ACETATE, DOCETAXEL. Patient was hospitalized. Patient died.

Lucrin Side Effects Report #5449499-2
Lucrin side effect was reported by a Consumer or non-health professional from BELGIUM on Aug 23, 2007. Male patient was diagnosed with prostate cancer  and was treated with Lucrin. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, metastases to bone, prostate cancer . Lucrin dosage: 11.25 MG (11.25 MG, 1 IN 3 M) ONGOING UNTIL DEATH. During the same period patient was treated with CYPROTERONE ACETATE, BICALUTAMIDE. Patient died.